This page gives details of CPPsite entry with ID 3003 |
| Primary information | |
|---|---|
| CPPsite ID | 3003 |
| PEPTIDE SEQUENCE | AGYLLGK[KK2sa4qn4]INLKALAALAKKIL |
| PEPTIDE NAME | Pepfect 5 |
| CHIRALITY | Modified |
| LINEAR/CYCLIC | Linear |
| SOURCE | Synthetic |
| CATEGORY | Amphipathic |
| N-TERMINAL MODIFICATION | Stearylation |
| C-TERMINAL MODIFICATION | Amidation |
| CHEMICAL MODIFICATION | sa: succinicc acid, qn: novel 2-4 ring systems such as quinoline and naphthalene analogues |
| PROPOSED UPTAKE MECHANISM | Endocytosis |
| INVITRO/INVIVO | In vitro |
| CELL LINE | Hela, Luciferase stable BHK21 cells |
| CARGO | Nucleic acid (anti-miR21 ON, siRNA) |
| PMID | 0 |
| PATENT | US 2014/0140929 A1 |
| LENGTH | 21 |
| Secondary Structure | NA |
| SMILES | NA |
| 3-D Structure | Not Predicted |